Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 489.81% and ...

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...

Buying $1000 In NVO: If an investor had bought $1000 of NVO stock 10 years ago, it would be worth $4,177.57 today based on a ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages ...

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

As the year comes to a close, the overall level of global mergers and acquisitions activity in 2024 is expected to be $3.5 ...

According to GoodRx, compliance rates are high, with only 9% of commercially insured people having full Zepbound coverage and 14% having full Wegovy coverage. This refers to insurance coverage that ...

Amazon may be known for its retail and tech chops, but the company has also built a strong operation in the healthcare realm ...

Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...

This report covers several pressing health topics, including WuXi's divestiture of its advanced therapies unit, the potential ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound from ... Data Source: IRIS by Real Chemistry | Image Credit: Real Chemistry ...